Literature DB >> 17114650

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

Christina A Clarke, Sally L Glaser, Connie S Uratsu, Joseph V Selby, Larry H Kushi, Lisa J Herrinton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17114650     DOI： 10.1200/JCO.2006.08.6504

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  53 in total

1.  Hormone therapy and fatal breast cancer.

Authors:  Sandra A Norman; Anita L Weber; A Russell Localio; Polly A Marchbanks; Giske Ursin; Brian L Strom; Linda K Weiss; Ronald T Burkman; Leslie Bernstein; Dennis M Deapen; Suzanne G Folger; Michael S Simon; Marion R Nadel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-05       Impact factor: 2.890

Review 2.  Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.

Authors:  Mark F Munsell; Brian L Sprague; Donald A Berry; Gary Chisholm; Amy Trentham-Dietz
Journal:  Epidemiol Rev       Date:  2014       Impact factor: 6.222

3.  Finally! A model for progesterone receptor action in normal human breast.

Authors:  John P Lydon; Dean P Edwards
Journal:  Endocrinology       Date:  2009-07       Impact factor: 4.736

4.  Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis.

Authors:  Eleni Linos; Demetri Spanos; Bernard A Rosner; Katerina Linos; Therese Hesketh; Jian Ding Qu; Yu-Tang Gao; Wei Zheng; Graham A Colditz
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

5.  Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium.

Authors:  Tehillah S Menes; Karla Kerlikowske; Shabnam Jaffer; Deborah Seger; Diana L Miglioretti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

6.  Generational risks for cancers not related to tobacco, screening, or treatment in the United States.

Authors:  Yueh-Ying Han; Devra L Davis; Joel L Weissfeld; Gregg E Dinse
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

7.  From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program.

Authors:  Jacqueline W Miller; Vivien Hanson; Gale D Johnson; Janet E Royalty; Lisa C Richardson
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

8.  Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.

Authors:  Lynn Rosenberg; Traci N Bethea; Emma Viscidi; Chi-Chen Hong; Melissa A Troester; Elisa V Bandera; Christopher A Haiman; Laurence N Kolonel; Andrew F Olshan; Christine B Ambrosone; Julie R Palmer
Journal:  J Natl Cancer Inst       Date:  2015-11-26       Impact factor: 13.506

Review 9.  Update in women's health.

Authors:  Judith M E Walsh; Mary S Beattie; Pamela Charney
Journal:  J Gen Intern Med       Date:  2009-12-18       Impact factor: 5.128

10.  Recent trends in breast cancer incidence in US white women by county-level urban/rural and poverty status.

Authors:  Amelia K Hausauer; Theresa H M Keegan; Ellen T Chang; Sally L Glaser; Holly Howe; Christina A Clarke
Journal:  BMC Med       Date:  2009-06-26       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.